Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 9, 2011, Pages 2750-2755

  Heilo, Arne ^a   Sigstad, Eva ^a   Fagerlid, Kristin Holgersen ^a   Has̊kjold, Olav Inge ^a   Grhøolt, Krystyna Kotanska ^a   Berner, Aasmund ^a,b   Bjrøo, Trine ^a,b   Jrøgensen, Lars H ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; THYROGLOBULIN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER GROWTH; CANCER SIZE; CANCER THERAPY; CERVICAL LYMPH NODE; CERVICAL LYMPH NODE METASTASIS; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; INJECTION SITE DISCOMFORT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; REOPERATION; THYROGLOBULIN BLOOD LEVEL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT RESPONSE; ULTRASOUND GUIDED PERCUTANEOUS ETHANOL INJECTION; ULTRASOUND THERAPY;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; ETHANOL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; THYROID NEOPLASMS; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 80052525801     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2952     Document Type: Article

References (26)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., Thun M. 2001 Cancer statistics, 2001. CA Cancer J Clin 51:15-36 (Pubitemid 32166444)
2. 2010 National Cancer Institute. Surveillance, epidemiology and end results: SEER cancer statistics review 1973-1997. http://seer.cancer. gov/publications
3. Hundahl S.A., Fleming I.D., Fremgen A.M., Menck H.R. 1998 A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]. Cancer 83: 2638-2648 (Pubitemid 29019586)
4. Hay I.D. 1990 Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545-576 (Pubitemid 20282656)
5. Hay I.D., Bergstralh E.J., Grant C.S., McIver B., Thompson G.B., Van Heerden J.A., Goellner J.R. 1999 Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. Surgery 126:1173-1181; discussion 1181-1182
6. Pacini F., Schlumberger M., Dralle H., Elisei R., Smit J.W., Wiersinga W. 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803 (Pubitemid 43997716)
7. Cooper D.S., Doherty G.M., Haugen B.R., Hauger B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Pacini F., Schlumberger M., Sherman S.I., Steward D.L., Tuttle R.M. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
8. Maxon 3rd H.R., Englaro E.E., Thomas S.R., Hertzberg V.S., Hinnefeld J.D., Chen L.S., Smith H., Cummings D., Aden M.D. 1992 Radioiodine- 131 therapy for well-differentiated thyroid cancer-a quantitative radiation dosimetric approach: Outcome and validation in 85 patients. J Nucl Med 33:1132-1136
9. Samaan N.A., Schultz P.N., Hickey R.C., Goepfert H., Haynie T.P., JohnstonD.A., Ordonez N.G. 1992 The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720
10. Sigstad E., Heilo A., Paus E., Holgersen K., Grøholt K.K., Jørgensen L.H., Bogsrud T.V., Berner A., Bjøro T. 2007 The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay. Diagn Cytopathol 35: 761-767 (Pubitemid 350250760)
11. Del Prete S., Caraglia M., Russo D., Vitale G., Giuberti G., Marra M., D'Alessandro A.M., Lupoli G., Addeo R., Facchini G., Rossiello R., Abbruzzese A., Capasso E. 2002 Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: Ten-year follow-up of a large series. Thyroid 12:815-821
12. Sung J.Y., Baek J.H., Kim Y.S., Jeong H.J., Kwak M.S., Lee D., Moon W.J. 2008 One-step ethanol ablation of viscous cystic thyroid nodules. AJR Am J Roentgenol 191:1730-1733
13. Livraghi T., Paracchi A., Ferrari C., Reschini E., Macchi R.M., Bonifacino A. 1994 Treatment of autonomous thyroid nodules with percutaneous ethanol injection: 4-year experience. Radiology 190: 529-533 (Pubitemid 24044265)
14. Veldman M.W., Reading C.C., Farrell M.A., Mullan B.P., Wermers R.A., Grant C.S., Thompson G.B. 2008 Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1. AJR Am J Roentgenol 191:1740-1744
15. Lewis B.D., Hay I.D., Charboneau J.W., McIver B., Reading C.C., Goellner J.R. 2002 Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol 178:699-704 (Pubitemid 34178153)
16. Kim B.M., Kim M.J., Kim E.K., Park S.I., Park C.S., Chung W.Y. 2008 Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol 18:835-842 (Pubitemid 351447779)
17. Lim C.Y., Yun J.S., Lee J., Nam K.H., Chung W.Y., Park C.S. 2007 Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid 17:347-350 (Pubitemid 46776139)
18. Monchik J.M., Donatini G., Iannuccilli J., Dupuy D.E. 2006 Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244:296-304 (Pubitemid 44305546)
19. Cibas E.S., Ali S.Z. 2009 The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 19:1159-1165
20. Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti A.E. 2010 AJCC cancer staging handbook. 7th ed. New York: Springer
21. Grubbs E.G., Evans D.B. 2007 Role of lymph node dissection in primary surgery for thyroid cancer. J Natl Compr Canc Netw 5:623-630 (Pubitemid 47057051)
22. Shen W.T., Ogawa L., Ruan D., Suh I., Duh Q.Y., Clark O.H. 2010 Central neck lymph node dissection for papillary thyroid cancer: The reliability of surgeon judgment in predicting which patients will benefit. Surgery 148:398-403
23. Caron N.R., Clark O.H. 2005 Papillary thyroid cancer: Surgical management of lymph node metastases. Curr Treat Options Oncol 6:311-322 (Pubitemid 41223385)
24. Bhattacharyya N. 2003 Surgical treatment of cervical nodal metastases in patients with papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 129:1101-1104 (Pubitemid 37248311)
25. Musacchio M.J., Kim A.W., Vijungco J.D., PrinzR.A.2003 Greater local recurrence occurs with "berry picking" than neck dissection in thyroid cancer. Am Surg 69:191-196; discussion 196-197
26. Shaha A.R. 2004 Prognostic factors in papillary thyroid carcinoma and implications of large nodal metastasis. Surgery 135:237-239 (Pubitemid 38130779)